Novartis India Limited

Company Profile

Novartis India Limited had its IPO on under the ticker symbol NOVARTIND.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Novartis India Limited has a staff strength of 67 employees.

Stock update

Shares of Novartis India Limited opened at ₹760 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹732 - ₹760, and closed at ₹747.55.

This is a -0.45% slip from the previous day's closing price.

A total volume of 1,513 shares were traded at the close of the day’s session.

In the last one week, shares of Novartis India Limited have increased by +4.55%.

Novartis India Limited's Key Ratios

Novartis India Limited has a market cap of ₹17.57 billion, indicating a price to book ratio of 2.2561 and a price to sales ratio of 4.0924.

In the last 12-months Novartis India Limited’s revenue was ₹3.48 billion with a gross profit of ₹2.56 billion and an EBITDA of ₹470.70 million. The EBITDA ratio measures Novartis India Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Novartis India Limited’s operating margin was 13.01% while its return on assets stood at 3.87% with a return of equity of 14.09%.

In Q2, Novartis India Limited’s quarterly earnings growth was a negative -61.3% while revenue growth was a negative 25.1%.

Novartis India Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

24.6399

PEG

Its diluted EPS in the last 12-months stands at ₹28.88 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Novartis India Limited’s profitability.

Novartis India Limited stock is trading at a EV to sales ratio of 2.7329 and a EV to EBITDA ratio of 17.2923. Its price to sales ratio in the trailing 12-months stood at 4.0924.

Novartis India Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 1.65%.

Balance sheet and cash flow metrics

Total Assets

₹9.83 billion

Total Liabilities

₹1.59 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

1.65%

Novartis India Limited ended 2024 with ₹9.83 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹9.83 billion while shareholder equity stood at ₹7.76 billion.

Novartis India Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.59 billion in other current liabilities, in common stock, ₹7.60 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹194.20 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Novartis India Limited’s total current assets stands at ₹6.77 billion while long-term investments were ₹0 and short-term investments were ₹5.50 billion. Its net receivables were ₹361.60 million compared to accounts payable of ₹596.70 million and inventory worth ₹547.20 million.

In 2024, Novartis India Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Novartis India Limited paid ₹0.02 in dividends in 2024.

Other key metrics

Current Trading Price

₹747.55

52-Week High

₹861.8

52-Week Low

₹524.8776

Analyst Target Price

₹

Novartis India Limited stock is currently trading at ₹747.55 per share. It touched a 52-week high of ₹861.8 and a 52-week low of ₹861.8. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹756.49 and 200-day moving average was ₹660.74 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7277.6% of the company’s stock are held by insiders while 14% are held by institutions.